Table 2.
Distribution of inflammatory and oxidative stress biomarkers and quality of life among the study participants
| Variable | Case group (n = 43) | Control group (n = 42) | P valuea |
|---|---|---|---|
| hs-CRP (g/mlµ) | 4.68 ± 4.36 | 2.92 ± 4.55 | 0.011 |
| TAC(mmol/L) | 2.46 ± 0.49 | 2.83 ± 0.82 | 0.065 |
| MDA (nmol/ml) | 2.63 ± 0.71 | 1.98 ± 0.90 | > 0.001 |
| SOD (U/ml) | 78.89 ± 37.93 | 154.25 ± 115.93 | > 0.001 |
| PLA2 (pg/ml) | 6.81 ± 2.22 | 4.73 ± 2.97 | > 0.001 |
| PF | 68.67 ± 2.631 | 75.89 ± 18.95 | 0.057 |
| RP | 34.44 ± 42.40 | 60.00 ± 42.44 | 0.004 |
| RE | 37.02 ± 41.57 | 59.98 ± 41.19 | 0.010 |
| EF | 55.50 ± 18.82 | 62.88 ± 20.35 | 0.077 |
| EW | 61.51 ± 16.87 | 67.75 ± 17.42 | 0.073 |
| SF | 62.55 ± 24.57 | 72.50 ± 24.65 | 0.033 |
| P | 48.5 ± 20.91 | 79.27 ± 28.38 | 0.028 |
| GH | 51.81 ± 20.91 | 63.13 ± 20.64 | 0.011 |
| PH | 202.97 ± 85.09 | 278.30 ± 88.36 | 0.001 |
| MH | 213.44 ± 79.18 | 264.61 ± 65.87 | 0.001 |
Values are means ± SD
CRP C-reactive protein, EF energy/fatigue, EW emotional wellbeing, GH general health, hs-CRP high-sensitive, MDA malondialdehyde, MH mental health, P pain, PF physical function, PH physical health, PLA phospholipase A2, RE role limitation due to emotional problems, RP role limitation due to physical health, SF social function, SOD superoxide dismutase, TAC total antioxidant capacity
aSignificantly different at p < 0.05 by Independent-Samples T test, Mann–Whitney U test or chi-square test